Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
Roberto Buonaiuto(University of Naples Federico II), Carmine De Angelis(Baylor College of Medicine), Giuseppe Neola(University of Naples Federico II), Grazia Arpino(University of Naples Federico II), Sabrina Chiara Cecere(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Mario Giuliano(Regione Campania), Amedeo Cefaliello(University of Naples Federico II), Aldo Caltavituro(University of Naples Federico II), Erica Pietroluongo(University of Naples Federico II), Pietro De Placido(University of Naples Federico II)
Cited by 14
Related Papers
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273